⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10917711 | 0.71 | — | — | |
| SCHEMBL2479 | 0.71 | — | — | |
| SCHEMBL519700 | 0.65 | NOS2 (0.39) | — | |
| SCHEMBL31059 | 0.64 | — | — | |
| SCHEMBL2139246 | 0.64 | — | — | |
| SCHEMBL21785045 | 0.64 | CRBN (0.47) | — | |
| SCHEMBL9058472 | 0.64 | CRBN (0.47) | — | |
| SCHEMBL11956432 | 0.63 | — | — | |
| Ammonia Solution, Strong SCHEMBL8471093 | 0.61 | CRBN (0.44) | — | |
| Hydrochloric Acid SCHEMBL5740143 | 0.61 | CRBN (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11981660-B2 | Neurite outgrowth promoters and uses thereof | UNIVERSITY OF MIAMI (US) | 2024-05-14 | — | — | US | claimed |
| WO-2024059010-A1 | COMPOUNDS FOR TREATING CANCER | GENESIS THERAPEUTICS, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| WO-2023245015-A2 | PHENYL AMIDE COMPOUNDS AND METHODS OF USE | SCHRÖDINGER, INC. (US) | 2023-12-21 | — | — | WO | claimed |
| CN-108026077-B | Phenoxymethyl derivatives | 豪夫迈·罗氏有限公司 | 2021-11-05 | — | — | CN | claimed |
| US-20210017162-A1 | NEURITE OUTGROWTH PROMOTERS AND USES THEREOF | UNIVERSITY OF MIAMI | 2021-01-21 | — | — | US | claimed |
| CN-107108660-B | Boronic acid derivatives | 默克专利股份公司 | 2020-09-15 | — | — | CN | claimed |
| WO-2019183369-A1 | NEURITE OUTGROWTH PROMOTERS AND USES THEREOF | UNIVERSITY OF MIAMI (US) | 2019-09-26 | — | — | WO | claimed |
| US-10370403-B2 | Methods for the synthesis of ceragenins | BRIGHAM YOUNG UNIVERSITY (US) | 2019-08-06 | — | — | US | claimed |
| US-20180207152-A1 | ANTICOAGULANT REVERSAL AGENTS | CIRAPARANTAG HOLDINGS GMBH (CH) | 2018-07-26 | — | — | US | claimed |
| US-20180194762-A1 | PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS LLC (US) | 2018-07-12 | — | — | US | claimed |
| WO-1995013075-A1 | METHOD FOR PREVENTING TISSUE INJURY FROM HYPOXIA | CELL THERAPEUTICS, INC. (US) | 1995-05-18 | — | — | WO | claimed |
| WO-1995012396-A1 | METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION | CELL THERAPEUTICS, INC. (US) | 1995-05-11 | — | — | WO | claimed |
| US-5328902-A | Antibiotics | AMERICAN CYANAMID CO. (US) | 1994-07-12 | — | — | US | claimed |
| CN-1087626-A | The glycyl that novel 7-(replacement)-8-(replacement)-9-[(replaces) amido]-6-demethyl-6-deoxidation tsiklomitsin | AMERICAN CYANAMID CO (US) | 1994-06-08 | — | — | CN | claimed |
| CN-1083805-A | 7-(replacement)-9-[(substituted glycyl) amido]-6-demethylation-6-deoxytetra cycline | AMERICAN CYANAMID CO (US) | 1994-03-16 | — | — | CN | claimed |
| EP-0582788-A1 | 7-(Substituted)-9- (substituted glycyl)-amido)-6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1994-02-16 | — | — | EP | claimed |
| EP-0582789-A1 | Novel 7-(substituted)-8-(substituted)-9- (substituted glycyl)amido -6-demethyl-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1994-02-16 | — | — | EP | claimed |
| EP-0405506-A1 | Tetrapeptide type-B CCK receptor ligands | ABBOTT LABORATORIES (US) | 1991-01-02 | — | — | EP | claimed |
| US-4587047-A | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines | E. R. SQUIBB & SONS, INC. (US) | 1986-05-06 | — | — | US | claimed |
| US-4386089-A | BACTERICIDES, GROWTH PROMOTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1983-05-31 | — | — | US | claimed |